 valid intermedi end point cancer research investig intermedi end point cancer surrog expens studi malign end point strategi biomark valid intermedi end point exposur incid cancer candid intermedi end point case seri ecolog studi anim experi prospect cohort case-control studi intermedi end point-canc associ appropri measur associ attribut proport intermedi end point valid cancer surrog attribut proport close attribut proport case valid surrogaci intermedi end point exposure-canc relat turn impli exposur effect intermedi end point rel advantag intervent observ studi valid intermedi end point valid strategi end point advers reproduct outcom chronic diseas cancer